Differentiation of L- and D-S-nitrosothiol recognition sites in vivo

Journal of Cardiovascular Pharmacology

Volumn 46, Issue 5, 2005, Pages 660-671

  Lewis, Stephen J ^a   Hoque, Azizul ^b   Bates, James N ^c  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Hemodynamics; Nitric oxide; Nitroblue tetrazolium; Rat; Redox; S nitrosocysteine

Indexed keywords

1 [N METHYL N [6 (N METHYLAMMONIOHEXYL)AMINO]DIAZEN 1 IUM 1,2 DIOLATE; DEXTRO S NITROSOTHIOL; LEVO S NITROSOTHIOL; NITRIC OXIDE DONOR; NITROBLUE TETRAZOLIUM; PENICILLAMINE; PENTOBARBITAL; S NITROSO BETA,BETA DIMETHYLCYSTEINE; S NITROSOTHIOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CELL TRANSPORT; CONTROLLED STUDY; DISULFIDE BOND; DOSE RESPONSE; DRUG BINDING SITE; ELECTRON TRANSPORT; FEMORAL VEIN; IN VIVO STUDY; LIPID TRANSPORT; MALE; MEAN ARTERIAL PRESSURE; MOLECULAR RECOGNITION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; STEREOISOMERISM; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; BINDING SITES; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMODYNAMIC PROCESSES; MALE; NITRIC OXIDE DONORS; NITROBLUE TETRAZOLIUM; RATS; RATS, SPRAGUE-DAWLEY; S-NITROSOTHIOLS; STEREOISOMERISM; VASCULAR RESISTANCE;

EID: 27344441067     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000181714.94827.5d     Document Type: Article

References (61)

1. Myers PR, Minor R Jr, Guerra R Jr, et al. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resembles S-nitrosocysteine than nitric oxide. Nature. 1990;345:161-163.
2. Rosenblum WI. Endothelium-derived relaxing factor in brain blood vessels is not nitric oxide. Stroke. 1992;23:1527-1535.
3. Batenburg WW, de Vries R, Saxena PR, et al. L-S-nitrosothiols: endothelium-derived hyperpolarizing factors in porcine coronary arteries? J Hypertens. 2004;22:1927-1936.
4. Batenburg WW, Popp R, Fleming I, et al. Bradykinin-induced relaxation of coronary microarteries: S-nitrosothiols as EDHF? Br J Pharmacol. 2004;142:125-135.
5. Kowaluk EA, Fung H. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J Pharmacol Exp Ther. 1990;25:1256-1264.
6. Mathews RW, Kerr SW. Biological activity of S-nitrosothiols: the role of nitric oxide. J Pharmacol Exp Ther. 1993;267:1529-1537.
7. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 1992;258:1898-1902.
8. Lipton SA, Choi Y, Pan Z, et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 1993;364:626-632.
9. Campbell DL, Stamler JS, Strauss HC. Redox modulation of L-type calcium channels in ferret ventricular myocytes: dual actions of nitric oxide and S-nitrosothiols. J Gen Physiol. 1996;108:277-293.
10. Stamler JS, Toone EJ, Lipton SA, et al. (S)NO signals: translocation, regulation, and a consensus motif. Neuron. 1997;18:691-696.
11. Ca) channels in myocytes of the guinea-pig taenia caeca. Br J Pharmacol. 2003;139:1153-1163.
12. Lewis SJ, Travis MD, Bates JN. Stereoselective S-nitrosocysteine recognition sites in rat brain. Eur J Pharmacol. 1996;312:R3-R5.
13. Davisson RL, Travis MD, Bates JN, et al. Hemodynamic effects of L- and D-S-nitrosocysteine in the rat: Stereoselective S-nitrosothiol recognition sites. Circ Res. 1996;79:256-262.
14. Davisson RL, Travis MD, Bates JN, et al. Stereoselective actions of S-nitrosocysteinc in the central nervous system of conscious rats. Am J Physiol. 1997;272:H2361-H2368.
15. Ohta H, Bates JN, Lewis SJ, et al. Actions of S-nitrosocysteine in the nucleus tractus solitarii unrelated to the release of nitric oxide. Brain Res. 1997;746:98-104.
16. Li X, Rose G, Dongre N, et al. S-nitroso-1-cysteine releases norepinephrine in rat spinal synaptosomes. Brain Res. 2000;872:301-307.
17. Lipton AJ, Johnson MA, Macdonald T, et al. S-nitrosothiols signal the ventilatory response to hypoxia. Nature. 2001;413:171-174.
18. Chen SR, Eisenach JC, Pan HL. Intrathecal S-nitroso-N-acetylpenicillamine and L-cysteine attenuate nerve injury-induced allodynia through noradrenergic activation. Neuroscience. 2000;101:759-765.
19. Travis MD, Stoll LL, Bates JN, et al. L-and D-S-nitroso-β,β- dimethylcysteine differentially increase cGMP in cultured vascular smooth muscle. Eur J Pharmacol. 1996;318:47-53.
20. Travis MD, Davisson RL, Bates JN, et al. Hemodynamic effects of L- and D-S-nitroso-β, β-dimethylcysteine in the rat. Am J Phvsiol. 1997;273: H1493-H1501.
21. 2+-channels markedly diminishes nitric oxide- but not L-S-nitrosocysteine- or endothelium-dependent vasodilation in vivo. Eur J Pharmacol. 2000; 408:289-298.
22. Hoque A, Bates J, Lewis SJ. In vivo evidence that L-S-nitrosocysteine may exert its vasodilator effects by interaction with thiol residues in the vasculature. Eur J Pharmacol. 1999;384:169-172.
23. Hoque A, Bates J, Lewis SJ. Redox regulation of S-nitrosocysteine- mediated vasodilation in vivo. Eur J Pharmacol. 2000;408:195-198.
24. Altman FP. Tetrazolium salts and formazans. Prog Histochem Cytochem. 1976;9:1-56.
25. Seidler E. The tetrazolium-formazan system: design and histochemistry. Prog Histochem Cytochem. 1991;24:1-86.
26. Altman FP. On the oxygen-sensitivity of various tetrazolium salts. Histochemie. 1970;22:256-261.
27. Altman FP. Studies on the reduction of tetrazolium salts. III. The products of chemical and enzymatic reduction. Histochemistry. 1974;38:155-171.
28. Seidler E. Experimental estimation of hydrophobic parameters of tetrazolium salts. Acta Histochem. 1995;97:295-299.
29. Seidler E, van Noorden JF. On the mechanism of the multistep reduction of tetrazolium salts with special reference to the involvement of tetrazolium radicals. Acta Histochem. 1994;96:43-49.
30. - radicals. J Phys Chem. 1980;84:830-833.
31. Thayer WS. Superoxide-dependent and superoxide-independent pathways for reduction of nitroblue tetrazolium in isolated cardiac myocytes. Arch Biochem Biophys. 1990;276:139-145.
32. Ernster L, Lee CP. Biological oxidoreductions. Annu Rev Biochem. 1964; 33:729-741.
33. Neugebauer FA. Hydrazidinyl-radikale: 1,2,4,5-tetraazapentenyle, verdazyle and tetrazolinyle. Angew Chem. 1973;85:485-493.
34. Findlay GH. The value of some tetrazolium salts as histochemical reagents for sulphydryl groups. J Histochem Cytochem. 1955;3:331-338.
35. Haywood JR, Shaffer RA, Fastenow C, et al. Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat. Am J Physiol. 1981;241:H273-H278.
36. Feelisch M. The biochemical pathways of nitric oxide formation from nitrovasodilators: Appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J Cardiovasc Pharmacol. 1991;17(suppl 3):25-33.
37. Ignarro L, Lippton H, Edwards JC, et al. Mechanisms of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 1981;218:739-749.
38. Winer BJ. Statistical Principles of Experimental Design. New York, NY: McGraw-Hill; 1971:752-809.
39. Wallenstein S, Zucker CL, Fleiss JC. Some statistical methods useful in circulation research. Circ Res. 1980;47:1-9.
40. Davisson RL, Walton TM, Johnson AK, et al. Cardiovascular effects produced by systemic injections of nitro blue tetrazolium (NBT) in the rat. Eur J Pharmacol. 1993;241:135-137.
41. Li S, Whorton AR. Identification of stereoselective transporters for S-nitroso-L-cysteine: Role of LAT1 and LAT2 in biological activity of S-nitrosothiols. J Biol Chem. 2005;280:20102-20110.
42. Zhang Y, Hogg N. The mechanism of transmembrane S-nitrosothiol transport. Proc Natl Acad Sci USA. 2004;101:7891-7896.
43. Mann GE, Yudilevich DL, Sobrevia L. Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev. 2003;83:183-252.
44. Bodoy S, Martin L, Zorzano A, et al. Identification of LAT4, a novel amino acid transporter with system L activity. J Biol Chem. 2005;280: 12002-12011.
45. Tang XD, Daggett H, Hanner M, et al. Oxidative regulation of large conductance calcium-activated potassium channels. J Gen Physiol. 2001; 117:253-274.
46. 2+-activated potassium channels via oxidation modulation in rat hippocampal CA1 pyramidal neurons. Eur J Neurosci. 2002;15:779-783.
47. Possas OS, Lewis SJ. Neurotransmitter pools of nitric oxide-containing factors may be diminished in lumbar sympathetic nerve terminals of Spontaneously Hypertensive rats. Hypertension. 1997;29:17.
48. + channels in resting state of carotid arteries from SHR. Am J Physiol. 1993;265:H843-H851.
49. Travis MD, Lewis SJ. Apparent association of MK-801-sensitive ion-channels with L-S-nitrosocysteine recognition sites in the hindlimb vasculature of the rat. Eur J Pharmacol. 2000;407:309-312.
50. Jia L, Bonaventura C, Bonaventura J, et al. S-nitrosohemoglobin: a dynamic activity of blood involved in vascular control. Nature. 1996; 380:221-226.
51. Stamler JS, Jaraki O, Osborne J, et al. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA. 1992;89:7674-7677.
52. Pistelli A, Mollace V, Nistico G, et al. Nitroblue tetrazolium inhibits oxidation of glyceryl trinitrate to nitric oxide in bovine aortic smooth muscle cells. Biochem Pharmacol. 1994;47:1737-1742.
53. Kooy NW, Lewis SJ, Royall JA, et al. Extensive tyrosine nitration in human myocardial inflammation: evidence for the presence of peroxynitrite. Crit Care Med. 1997;25:812-819.
54. Kovacic P, Thurn LA. Cardiovascular toxicity from the perspective of oxidative stress, electron transfer, and prevention by antioxidants. Curr Vasc Pharmacol. 2005;3:107-117.
55. Davisson RL, Bates JN, Johnson AK, et al. Use-dependent loss of acetylcholine- and bradykinin-mediated after NO synthase inhibition: evidence for preformed stores of NO-containing factors in vascular endothelial cells. Hypertension. 1996;28:354-360.
56. Danser AHJ, De Vries R, Schoemaker RG, et al. Bradykinin-induced release of nitric oxide by the isolated perfused rat heart: importance of preformed pools of nitric-oxide containing factors. J Hypertens. 1998;16:239-244.
57. Danser AJ, Tom B, De Vries R, et al. L-NAME-resistant bradykinin relaxation in porcine coronary arteries is NO-dependent. Effect of ACE inhibition. Br J Pharmacol. 2000;131:195-202.
58. Davisson RL, Shaffer RA, Johnson AK, et al. Stimulation of lumbar sympathetic nerves may produce hindlimb vasodilation via the release of pre-formed stores of nitrosyl factors. Neuroscience. 1996;72:881-887.
59. Davisson RL, Possas OS, Murphy SP, et al. Neurogenically-derived nitrosyl factors mediate lumbar sympathetic vasodilation in the hindlimb vasculature of the rat. Am J Physiol. 1997;272:H2369-H2376.
60. Davisson RL, Shaffer RA, Johnson AK, et al. Use-dependent loss of active sympathetic neurogenic vasodilation following nitric oxide synthase inhibition in conscious rats: evidence for the presence of preformed stores of nitric oxide-containing factors. Hypertension. 1996; 28:347-353.
61. Possas OS, Lewis SJ. NO-containing factors mediate reflex hindlimb vasodilation produced by superior laryngeal nerve stimulation. Am J Physiol. 1997;273:H234-H243.